Browse > Article
http://dx.doi.org/10.5483/BMBRep.2022.55.2.169

Aurora kinase A induces migration and invasion by inducing epithelial-to-mesenchymal transition in colon cancer cells  

Hong, On-Yu (Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School)
Kang, Sang Yull (Department of Surgery, Research Institute of Clinical Medicine of Jeonbuk National University and Biomedical Research Institute of Jeonbuk National University Hospital)
Noh, Eun-Mi (Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School)
Yu, Hong-Nu (Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School)
Jang, Hye-Yeon (Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School)
Kim, Seong-Hun (Division of Gastroenterology, Department of Internal Medicine, Research Institute of Clinical Medicine, Jeonbuk National University Medical School and Hospital)
Hong, Jingyu (Department of Anesthesiology and Pain Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
Chung, Eun Yong (Department of Anesthesiology and Pain Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
Kim, Jong-Suk (Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School)
Publication Information
BMB Reports / v.55, no.2, 2022 , pp. 87-91 More about this Journal
Abstract
Aurora kinase is a family of serine/threonine kinases intimately associated with mitotic progression and the development of human cancers. Studies have shown that aurora kinases are important for the protein kinase C (PKC)-induced invasion of colon cancer cells. Recent studies have shown that aurora kinase A promotes distant metastasis by inducing epithelial-to-mesenchymal transition (EMT) in colon cancer cells. However, the role of aurora kinase A in colon cancer metastasis remains unclear. In this study, we investigated the effects of aurora kinase A on PKC-induced cell invasion, migration, and EMT in human SW480 colon cancer cells. Treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA) changed the expression levels of EMT markers, increasing α-SMA, vimentin, and MMP-9 expression and decreasing E-cadherin expression, with changes in cell morphology. TPA treatment induced EMT in a PKC-dependent manner. Moreover, the inhibition of aurora kinase A by siRNAs and inhibitors (reversine and VX-680) suppressed TPA-induced cell invasion, migration, and EMT in SW480 human colon cells. Inhibition of aurora kinase A blocked TPA-induced vimentin and MMP-9 expression, and decreased E-cadherin expression. Furthermore, the knockdown of aurora kinase A decreased the transcriptional activity of NF-κB and AP-1 in PKC-stimulated SW480 cells. These findings indicate that aurora kinase A induces migration and invasion by inducing EMT in SW480 colon cancer cells. To the best of our knowledge, this is the first study that showed aurora kinase A is a key molecule in PKC-induced metastasis in colon cancer cells.
Keywords
Aurora kinase A; Colon cancer; Epithelia-to-mesenchymal transition; Matrix metalloproteinase-9; Protein kinase C;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Masur K, Lang K, Niggemann B, Zanker KS and Entschladen F (2001) High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells. Mol Biol Cell 12, 1973-1982   DOI
2 D'Assoro, AB, Liu T, Quatraro C et al (2014) The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERalpha(+) breast cancer cells. Oncogene 33, 599-610   DOI
3 Bauvois B (2012) New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta 1825, 29-36
4 Julien S, Puig I, Caretti E et al (2007) Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26, 7445-7456   DOI
5 Privette LM and Petty EM (2008) CHFR: a novel mitotic checkpoint protein and regulator of tumorigenesis. Transl Oncol 1, 57-64   DOI
6 Tarafdar A and Michie AM (2014) Protein kinase C in cellular transformation: a valid target for therapy? Biochem Soc Trans 42, 1556-1562   DOI
7 Nam EH, Lee Y, Moon B, Lee JW and Kim S (2015) Twist1 and AP-1 cooperatively upregulate integrin alpha5 expression to induce invasion and the epithelial-mesenchymal transition. Carcinogenesis 36, 327-337   DOI
8 Steeghs N, Eskens FA, Gelderblom H et al (2009) Phase I pharmacokinetic and pharmacodynamic study of the aurora kinase inhibitor danusertib in patients with advanced or metastatic solid tumors. J Clin Oncol 27, 5094-5101   DOI
9 Bakiri L, Macho-Maschler S, Custic I (2015) Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression. Cell Death Differ 22, 336-350   DOI
10 Julien S, Puig I, Caretti E et al (2007) Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26, 7445-7456   DOI
11 Yu X, Minter-Dykhouse K, Malureanu L et al (2005) Chfr is required for tumor suppression and Aurora A regulation. Nat Genet 37, 401-406   DOI
12 Tang A, Gao K, Chu L, Zhang R, Yang J and Zheng J (2017) Aurora kinases: novel therapy targets in cancers. Oncotarget 8, 23937-23954   DOI
13 Noh EM, Lee YR, Hong OY, Jung SH, Youn HJ and Kim JS (2015) Aurora kinases are essential for PKC-induced invasion and matrix metalloproteinase-9 expression in MCF-7 breast cancer cells. Oncol Rep 34, 803-810   DOI
14 Siegel R, Naishadham D and Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63, 11-30   DOI
15 Jemal A, Center MM, DeSantis C and Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19, 1893-1907   DOI
16 Thiery JP and Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7, 131-142   DOI
17 Batlle E, Sancho E, Franci C et al (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2, 84-89   DOI
18 Parekh DB, Ziegler W and Parker PJ (2000) Multiple pathways control protein kinase C phosphorylation. EMBO J 19, 496-503   DOI
19 Serova M, Ghoul A, Benhadji KA et al (2006) Preclinical and clinical development of novel agents that target the protein kinase C family. Semin Oncol 33, 466-478   DOI
20 D'Assoro AB, Haddad T and Galanis E (2015) Aurora-A kinase as a promising therapeutic target in cancer. Front Oncol 5, 295   DOI
21 Mathias RA, Gopal SK and Simpson RJ (2013) Contribution of cells undergoing epithelial-mesenchymal transition to the tumour microenvironment. J Proteomics 78, 545-557   DOI
22 Goos JA, Coupe VM, Diosdado B et al (2013) Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis. Br J Cancer 109, 2445-2452   DOI
23 Stetler-Stevenson WG (1999) Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 103, 1237-1241   DOI
24 Nomura A, Majumder K, Giri B et al (2016) Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer. Lab Invest 96, 1268-1278   DOI
25 Carvajal RD, Tse A and Schwartz GK (2006) Aurora kinases: new targets for cancer therapy. Clin Cancer Res 12, 6869-6875   DOI
26 Du R, Huang C, Liu K, Li X and Dong Z (2021) Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy. Mol Cancer 20, 15   DOI
27 Usman S, Waseem NH, Nguyen TKN et al (2021) Vimentin is at the heart of epithelial mesenchymal transition (emt) mediated metastasis. Cancers (Basel) 13, 4985   DOI